Previous

DFW Healthcare Brief: Medical City Fort Worth Accolades and Signify’s New Partnerships
Next

Lantern Pharma Receives Rare Pediatric Disease and Orpan Drug Designations for LP-184 for the Treatment of Atypical Teratoid Rhabdoid Tumor (ATRT)